Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 4
2004 3
2006 1
2009 2
2010 1
2011 1
2012 3
2014 2
2015 1
2017 2
2018 1
2019 1
2021 2
2022 1
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
[Update on treatment of bladder cancer].
Visockiene R, Inciūra A, Juozaityte E. Visockiene R, et al. Among authors: inciura a. Medicina (Kaunas). 2004;40(12):1239-48. Medicina (Kaunas). 2004. PMID: 15630352 Free article. Review. Lithuanian.
[The update on pancreatic cancer chemotherapy].
Brasiūniene B, Juozaityte E, Brasiūnas V, Inciūra A. Brasiūniene B, et al. Among authors: inciura a. Medicina (Kaunas). 2003;39(10):1016-25. Medicina (Kaunas). 2003. PMID: 14578647 Free article. Review. Lithuanian.
[Surgical treatment of advanced epithelial ovarian cancer].
Inciūra A, Juozaityte E, Nadisauskiene R, Cigriejiene VM, Kajenas S, Vaitkiene D, Vaidotiene L, Simavicius A. Inciūra A, et al. Medicina (Kaunas). 2004;40(3):205-15. Medicina (Kaunas). 2004. PMID: 15064540 Free article. Review. Lithuanian.
31 results